Amicus Therapeutics

Philadelphia, Pennsylvania
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Clear
Lower Risk

Summary:

Amicus Therapeutics does not yield to political activism in shaping corporate governance, preventing initiatives that potentially alienate consumers, divide employees, and harm shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Overall, Amicus Therapeutics does not embrace corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach protects free exercise, free speech, and free enterprise.

View Full Corporate Bias Ratings Report
Generate Reports
Clear
Toast